Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth M Shermock

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 6, 2008
Erythropoietic agents for anemia of critical illnessKenneth M Shermock, Ed Horn, Ted L Rice
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 30, 2010
A superior method to report clinically relevant quality information about the point-of-care INR device performance compared with the International Organization for Standardization guidelinesKenneth M Shermock, William Clarke, Michael B Streiff
Expert Opinion on Investigational Drugs|September 13, 2002
Investigational pharmacologic treatment for liver diseaseLori L Siatkosky, Kenneth M Shermock, Zobair M Younossi
International Journal of Environmental Research and Public Health|September 8, 2023
Closed-Loop Medication Management with an Electronic Health Record System in U.S. and Finnish HospitalsSusan B Shermock, Kenneth M Shermock, Lotta L Schepel
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 22, 2020
Barriers to biosimilar utilization in the United StatesStacy Elder Dalpoas, Mariana Socal, Celia Proctor, et al.
Journal of Managed Care & Specialty Pharmacy|September 25, 2018
Costs Associated with Productivity Loss Among U.S. Patients Newly Diagnosed with Multiple Myeloma Receiving Oral Versus Injectable ChemotherapyDavid Merola, Candice Yong, Stephen J Noga, et al.
Pharmacotherapy|August 19, 2003
Comparative study of the development of diabetes mellitus in patients taking risperidone and olanzapineMatthew A Fuller, Kenneth M Shermock, Michelle Secic, et al.
COPD|December 7, 2006
Cost-effectiveness of population screening for alpha-1 antitrypsin deficiency: a decision analysisKenneth M Shermock, Thomas R Gildea, Mendel Singer, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 15, 2008
Clinical outcomes of patients with diabetes mellitus receiving medication management by pharmacists in an urban private physician practiceNancy T Nkansah, Jeffrey M Brewer, Robert Connors, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 19, 2010
Assessment of agreement between INR measures must correspond to a clinical realityKenneth M Shermock, Jason T Connor, Danielle C Lavallee, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 6, 2008
Erythropoietic agents for anemia of critical illnessKenneth M Shermock, Ed Horn, Ted L Rice
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 30, 2010
A superior method to report clinically relevant quality information about the point-of-care INR device performance compared with the International Organization for Standardization guidelinesKenneth M Shermock, William Clarke, Michael B Streiff
Expert Opinion on Investigational Drugs|September 13, 2002
Investigational pharmacologic treatment for liver diseaseLori L Siatkosky, Kenneth M Shermock, Zobair M Younossi
International Journal of Environmental Research and Public Health|September 8, 2023
Closed-Loop Medication Management with an Electronic Health Record System in U.S. and Finnish HospitalsSusan B Shermock, Kenneth M Shermock, Lotta L Schepel
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 22, 2020
Barriers to biosimilar utilization in the United StatesStacy Elder Dalpoas, Mariana Socal, Celia Proctor, et al.
Journal of Managed Care & Specialty Pharmacy|September 25, 2018
Costs Associated with Productivity Loss Among U.S. Patients Newly Diagnosed with Multiple Myeloma Receiving Oral Versus Injectable ChemotherapyDavid Merola, Candice Yong, Stephen J Noga, et al.
Pharmacotherapy|August 19, 2003
Comparative study of the development of diabetes mellitus in patients taking risperidone and olanzapineMatthew A Fuller, Kenneth M Shermock, Michelle Secic, et al.
COPD|December 7, 2006
Cost-effectiveness of population screening for alpha-1 antitrypsin deficiency: a decision analysisKenneth M Shermock, Thomas R Gildea, Mendel Singer, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 15, 2008
Clinical outcomes of patients with diabetes mellitus receiving medication management by pharmacists in an urban private physician practiceNancy T Nkansah, Jeffrey M Brewer, Robert Connors, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 19, 2010
Assessment of agreement between INR measures must correspond to a clinical realityKenneth M Shermock, Jason T Connor, Danielle C Lavallee, et al.
Pageof 8